Literature DB >> 2253475

Inhibition of intrinsic protein tyrosine kinase activity of EGF-receptor kinase complex from human breast cancer cells by the marine sponge metabolite (+)-aeroplysinin-1.

M H Kreuter1, R E Leake, F Rinaldi, W Müller-Klieser, A Maidhof, W E Müller, H C Schröder.   

Abstract

1. (+)-Aeroplysinin-1, a naturally occurring tyrosine metabolite from the marine sponge Verongia aerophoba, was found to inhibit the phosphorylation of lipocortin-like proteins by a highly purified preparation of the epidermal growth factor (EGF) receptor-tyrosine protein kinase complex from MCF-7 breast carcinoma cells. 2. (+)-Aeroplysinin-1 blocked the EGF-dependent proliferation of both MCF-7 and ZR-75-1 human breast cancer cells and inhibited the ligand-induced endocytosis of the EGF receptor in vitro. 3. Treatment with aeroplysinin-1 in the concentration range at 0.25-0.5 microM resulted in a time- and dose-dependent total tumor cell death in vitro. 4. At a 10-fold higher concentration the compound did not reveal any cytostatic activity in normal human fibroblasts. 5. From these data we conclude that (+)-aeroplysinin-1 represents a compound which displays a strong anti-tumor effect on EGF-dependent tumor cell lines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253475     DOI: 10.1016/0305-0491(90)90194-x

Source DB:  PubMed          Journal:  Comp Biochem Physiol B        ISSN: 0305-0491


  18 in total

Review 1.  The marine bromotyrosine derivatives.

Authors:  Jiangnan Peng; Jing Li; Mark T Hamann
Journal:  Alkaloids Chem Biol       Date:  2005

Review 2.  Principles of biofouling protection in marine sponges: a model for the design of novel biomimetic and bio-inspired coatings in the marine environment?

Authors:  Werner E G Müller; Xiaohong Wang; Peter Proksch; Carole C Perry; Ronald Osinga; Johan Gardères; Heinz C Schröder
Journal:  Mar Biotechnol (NY)       Date:  2013-03-26       Impact factor: 3.619

3.  Targeting Mechanisms of the DNA Damage Response (DDR) and DNA Repair by Natural Compounds to Improve cAT-Triggered Tumor Cell Death.

Authors:  Jana Aengenvoort; Marlena Sekeres; Peter Proksch; Gerhard Fritz
Journal:  Molecules       Date:  2022-06-01       Impact factor: 4.927

4.  Iodocionin, a cytotoxic iodinated metabolite from the Mediterranean ascidian Ciona edwardsii.

Authors:  Anna Aiello; Ernesto Fattorusso; Concetta Imperatore; Marialuisa Menna; Werner E G Müller
Journal:  Mar Drugs       Date:  2010-02-21       Impact factor: 5.118

Review 5.  Mechanism targeted discovery of antitumor marine natural products.

Authors:  Dale G Nagle; Yu-Dong Zhou; Flor D Mora; Kaleem A Mohammed; Yong-Pil Kim
Journal:  Curr Med Chem       Date:  2004-07       Impact factor: 4.530

6.  Identification of novel host-targeted compounds that protect from anthrax lethal toxin-induced cell death.

Authors:  Louise H Slater; Erik C Hett; Kevin Mark; Nicole M Chumbler; Deepa Patel; D Borden Lacy; R John Collier; Deborah T Hung
Journal:  ACS Chem Biol       Date:  2013-02-04       Impact factor: 5.100

Review 7.  Kinase inhibitors from marine sponges.

Authors:  Danielle Skropeta; Natalie Pastro; Ana Zivanovic
Journal:  Mar Drugs       Date:  2011-10-24       Impact factor: 6.085

8.  The brominated compound aeroplysinin-1 inhibits proliferation and the expression of key pro- inflammatory molecules in human endothelial and monocyte cells.

Authors:  Beatriz Martínez-Poveda; Javier A García-Vilas; Casimiro Cárdenas; Esther Melgarejo; Ana R Quesada; Miguel A Medina
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

9.  The antiangiogenic compound aeroplysinin-1 induces apoptosis in endothelial cells by activating the mitochondrial pathway.

Authors:  Beatriz Martínez-Poveda; Salvador Rodríguez-Nieto; Melissa García-Caballero; Miguel-Ángel Medina; Ana R Quesada
Journal:  Mar Drugs       Date:  2012-09-18       Impact factor: 6.085

10.  Traditional and Modern Biomedical Prospecting: Part II-the Benefits: Approaches for a Sustainable Exploitation of Biodiversity (Secondary Metabolites and Biomaterials from Sponges).

Authors:  Werner E G Müller; Heinz C Schröder; Matthias Wiens; Sanja Perović-Ottstadt; Renato Batel; Isabel M Müller
Journal:  Evid Based Complement Alternat Med       Date:  2004-09-01       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.